Argan (AGX) | Q4 1995 | 7,000.25% |
Gyrodyne Company of America (GYRO) | Q3 1995 | 910.07% |
Idaho Strategic Resources (IDR) | Q3 1995 | 525% |
American Shared Hospital Service (AMS) | Q2 1995 | 420.08% |
AutoNation (AN) | Q2 1995 | 375.81% |
Semtech (SMTC) | Q1 1995 | 338.13% |
NVE (NVEC) | Q2 1995 | 300% |
Onto Innovation (ONTO) | Q2 1995 | 225% |
Abeona Therapeutics (ABEO) | Q4 1995 | 209.09% |
Hudson Technologies (HDSN) | Q1 1995 | 200% |
Champions Oncology (CSBR) | Q3 1995 | 175% |
Onto Innovation (ONTO) | Q1 1995 | 170% |
Lifevantage (LFVN) | Q4 1995 | 150% |
Sanara Medtech (SMTI) | Q4 1995 | 150% |
Riley Exploration Permian (REPX) | Q2 1995 | 149.99% |
Biogen (BIIB) | Q4 1995 | 147.62% |
Kulicke and Soffa Industries (KLIC) | Q2 1995 | 142.24% |
Riley Exploration Permian (REPX) | Q3 1995 | 140% |
NetApp (NTAP) | Q4 1995 | 132.63% |
CryoCell International (CCEL) | Q1 1995 | 131.25% |
Interlink Electronics (LINK) | Q2 1995 | 128.57% |
Bausch Health Companies (BHC) | Q4 1995 | 125.53% |
Lineage Cell Therapeutics (LCTX) | Q3 1995 | 125.03% |
Coherent (COHR) | Q2 1995 | 121.96% |
Electro-Sensors (ELSE) | Q3 1995 | 119.99% |
